Apolipoprotein B [aapp, bacs]
synthesis [biof]
Inhibition [menp]
mipomersen [nnon, phsu]
Heterozygous [orga]
Familial hypercholesterolaemia [dsyn]
Background [cnce]
Heterozygous [orga]
Familial hypercholesterolaemia [dsyn]
Common [qnco]
Genetic Disorder [dsyn]
Leading [tmco]
Coronary artery disease, premature [fndg]
Statins [orch, phsu]
Additional [ftcn]
Lipid-lowering therapy [topp]
Heterozygous [orga]
Familial hypercholesterolaemia [dsyn]
Patients [podg]
fail [ftcn]
To [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Goals [inpr]
Evaluated [ftcn]
mipomersen [nnon, phsu]
Apolipoprotein B [aapp, bacs]
synthesis [biof]
Inhibitor [qlco]
To [qlco]
Further [spco]
Lower [spco]
Heterozygous [orga]
Familial hypercholesterolaemia [dsyn]
Patients [podg]
coronary artery disease [dsyn]
Methods [inpr]
Result [ftcn]
thi [euka]
DOUBLE BLIND [resa]
placebo [topp]
controlled trial randomized [inpr, resa]
Patients [podg]
Heterozygous [orga]
Familial hypercholesterolaemia [dsyn]
coronary artery disease [dsyn]
Statin [orch, phsu]
mmol/L [qnco]
mg dl [qnco]
To [qlco]
Weekly [tmco]
subcutaneous [spco]
mipomersen [nnon, phsu]
mg% [qnco]
placebo [topp]
weeks [tmco]
Primary Endpoint [irda]
Percent [qnco]
Change [ftcn]
baseline [bodm]
Safety [hcpp]
assessments [hlca]
included [ftcn]
adverse events [fndg]
Laboratory Tests [lbpr]
Magnetic Resonance Imaging [diap]
Assessment [hlca]
Hepatic [blor]
randomized [resa]
Patients [podg]
placebo [topp]
mipomersen [nnon, phsu]
placebo [topp]
mipomersen [nnon, phsu]
COMPLETED [qlco]
treatment [ftcn]
Mean [qnco]
Confidence Interval [qnco]
Decreased [qnco]
mipomersen [nnon, phsu]
Compared [acty]
Increase [ftcn]
placebo [topp]
P NOS [aapp, imft]
mipomersen [nnon, phsu]
Reduced [qlco]
Apolipoprotein B [aapp, bacs]
Total Cholesterol [lbpr]
Lipoprotein (a) [aapp, bacs]
Compared [acty]
placebo [topp]
P NOS [aapp, imft]
Change [ftcn]
Occurred [acty]
High Density Lipoprotein Cholesterol [bacs, lipd]
adverse events [fndg]
included [ftcn]
Injection site reaction [patf]
Influenza-like symptoms [sosy]
Five [qnco]
mipomersen [nnon, phsu]
Patients [podg]
Consecutive [qlco]
Alanine Aminotransferase [aapp, enzy]
Values [qlco]
times [tmco]
Upper [spco]
limit [ftcn]
Normal [qlco]
days [tmco]
Associated [qlco]
Bilirubin [bacs, orch]
increases [ftcn]
Hepatic [blor]
Content [menp]
Increased [qnco]
median [spco]
mipomersen [nnon, phsu]
placebo [topp]
P NOS [aapp, imft]
Conclusions [idcn]
mipomersen [nnon, phsu]
effective [qlco]
therapy [ftcn]
Further [spco]
Apolipoprotein B [aapp, bacs]
Containing [ftcn]
Lipoproteins [aapp, bacs]
Including [ftcn]
Lipoprotein (a) [aapp, bacs]
Heterozygous [orga]
Familial hypercholesterolaemia [dsyn]
Patients [podg]
coronary artery disease [dsyn]
Statins [orch, phsu]
Lipid-lowering therapy [topp]
Significance [qnco]
Hepatic [blor]
Transaminase [aapp, enzy]
increases [ftcn]
Uncertain [idcn]
Time [tmco]
Clinical Trial [resa]
Registration [hlca]
URL [inpr]
HTTP [idcn]
WWW [mnob]
GOV [gngm]
Unique Identifier [inpr]
Circulation [phsf]
